Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedNov 24, 2021LOTRIMIN AFcGMP Deviations: LOTRIMIN AF (Tolnaftate 1%) manufactured at the same facility where other lots were found to be contaminated with benzene.Bayer Healthcare Pharmaceuticals Inc. · D-0254-2022Class ITerminatedNov 24, 2021TinactinChemical Contamination: presence of benzeneBayer Healthcare Pharmaceuticals Inc. · D-0253-2022Class ITerminatedNov 24, 2021TinactinChemical Contamination: presence of benzeneBayer Healthcare Pharmaceuticals Inc. · D-0252-2022Class ITerminatedNov 24, 2021TinactinChemical Contamination: presence of benzeneBayer Healthcare Pharmaceuticals Inc. · D-0251-2022Class ITerminatedNov 24, 2021TinactinChemical Contamination: presence of benzeneBayer Healthcare Pharmaceuticals Inc. · D-0250-2022Class ITerminatedNov 24, 2021Lotrimin AFChemical Contamination: presence of benzeneBayer Healthcare Pharmaceuticals Inc. · D-0249-2022Class ITerminatedNov 24, 2021LOTRIMIN AFChemical Contamination: presence of benzeneBayer Healthcare Pharmaceuticals Inc. · D-0248-2022Class ITerminatedNov 24, 2021LOTRIMIN AFChemical Contamination: presence of benzeneBayer Healthcare Pharmaceuticals Inc. · D-0247-2022Class ITerminatedNov 24, 2021LOTRIMIN AFChemical Contamination: presence of benzeneBayer Healthcare Pharmaceuticals Inc. · D-0246-2022Class IITerminatedNov 24, 2021TinactincGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.Bayer Healthcare Pharmaceuticals Inc. · D-0245-2022Class IITerminatedNov 24, 2021TinactincGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.Bayer Healthcare Pharmaceuticals Inc. · D-0244-2022Class IITerminatedNov 24, 2021TinactincGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.Bayer Healthcare Pharmaceuticals Inc. · D-0243-2022Class IITerminatedNov 24, 2021TinactincGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.Bayer Healthcare Pharmaceuticals Inc. · D-0242-2022Class IITerminatedNov 24, 2021Lotrimin AFcGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.Bayer Healthcare Pharmaceuticals Inc. · D-0241-2022Class IITerminatedNov 24, 2021LOTRIMIN AFcGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.Bayer Healthcare Pharmaceuticals Inc. · D-0240-2022Class IITerminatedNov 24, 2021LOTRIMIN AFcGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.Bayer Healthcare Pharmaceuticals Inc. · D-0239-2022Class IITerminatedNov 24, 2021LOTRIMIN AFcGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.Bayer Healthcare Pharmaceuticals Inc. · D-0238-2022Class IITerminatedNov 24, 2021LOTRIMIN AFcGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.Bayer Healthcare Pharmaceuticals Inc. · D-0237-2022Class IITerminatedNov 24, 2021LOTRIMIN AFcGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.Bayer Healthcare Pharmaceuticals Inc. · D-0236-2022Class IIITerminatedNov 24, 2021Clonidine Transdermal SystemFailed Impurities/Degradation SpecificationsTeva Pharmaceuticals USA · D-0235-2022Class IITerminatedNov 24, 2021Flocinolone Acetonide 0.01% Topical OilSubpotent Drug: Out-of-specification assay result was obtained for Fluocinolone Acetonide.Amneal Pharmaceuticals of New York, LLC · D-0234-2022Class IITerminatedNov 24, 2021Flocinolone Acetonide 0.01% Topical OilSubpotent Drug: Out-of-specification assay result was obtained for Fluocinolone Acetonide.Amneal Pharmaceuticals of New York, LLC · D-0233-2022Class IITerminatedNov 24, 2021Cartia XTLabelling: Incorrect Exp. DateTeva Pharmaceuticals USA · D-0232-2022Class IITerminatedNov 17, 2021Tadalafil TabletsIncorrect Product Formulation: An incorrect grade of Crospovidone was used to manufacture the product.Sun Pharmaceutical Industries Inc · D-0231-2022Class IITerminatedNov 17, 2021Tadalafil TabletsIncorrect Product Formulation: An incorrect grade of Crospovidone was used to manufacture the product.Sun Pharmaceutical Industries Inc · D-0230-2022Class IITerminatedNov 17, 2021Cefixime Capsules 400 mgFailed Impurities/Degradation SpecificationsAscend Laboratories LLC · D-0229-2022Class IITerminatedNov 17, 2021Ezetimibe and Simvastatin TabletsFailed Excipient Specification; product manufactured using an excipient found to be OOS for conductivityGolden State Medical Supply Inc. · D-0228-2022Class IITerminatedNov 17, 2021Ezetimibe and Simvastatin TabletsFailed Excipient Specifications and Presence of Foreign Tablets/Capsules; product manufactured using an excipient found to be OOS for conductivity and some Ezetimibe and...Golden State Medical Supply Inc. · D-0227-2022Class IITerminatedNov 17, 2021TRI-MIX PAPAVERINE 40/PHENTOLAMINE 2/PGE-1 40 INJ INJECTABLELack of assurance of sterilityVita Pharmacy, LLC dba Talon Compounding Pharmacy · D-0226-2022Class IITerminatedNov 17, 2021TRI-MIX PAPAVERINE 40/PHENTOLAMINE 2/PGE-1 10 INJ INJECTABLELack of assurance of sterilityVita Pharmacy, LLC dba Talon Compounding Pharmacy · D-0225-2022Class IITerminatedNov 17, 2021TRI-MIX PAPAVERINE 30/PHENTOLAMINE 6/PGE-1 60 INJ INJECTABLELack of assurance of sterilityVita Pharmacy, LLC dba Talon Compounding Pharmacy · D-0224-2022Class IITerminatedNov 17, 2021TRI-MIX PAPAVERINE 30/PHENTOLAMINE 4/PGE-1 7.5/ML INJ INJECTABLELack of assurance of sterilityVita Pharmacy, LLC dba Talon Compounding Pharmacy · D-0223-2022Class IITerminatedNov 17, 2021TRI-MIX PAPAVERINE 30/PHENTOLAMINE 4/PGE-1 60 INJ INJECTABLELack of assurance of sterilityVita Pharmacy, LLC dba Talon Compounding Pharmacy · D-0222-2022Class IITerminatedNov 17, 2021TRI-MIX PAPAVERINE 30/PHENTOLAMINE 4/PGE-1 5 INJ INJECTABLELack of assurance of sterilityVita Pharmacy, LLC dba Talon Compounding Pharmacy · D-0221-2022Class IITerminatedNov 17, 2021TRI-MIX PAPAVERINE 30/PHENTOLAMINE 4/PGE-1 20 INJ INJECTABLELack of assurance of sterilityVita Pharmacy, LLC dba Talon Compounding Pharmacy · D-0220-2022Class IITerminatedNov 17, 2021TRI-MIX PAPAVERINE 30/PHENTOLAMINE 3/PGE-1 40 INJ INJECTABLELack of assurance of sterilityVita Pharmacy, LLC dba Talon Compounding Pharmacy · D-0219-2022Class IITerminatedNov 17, 2021TRI-MIX PAPAVERINE 30/PHENTOLAMINE 3/PGE-1 40 INJ INJECTABLELack of assurance of sterilityVita Pharmacy, LLC dba Talon Compounding Pharmacy · D-0218-2022Class IITerminatedNov 17, 2021TRI-MIX PAPAVERINE 30/PHENTOLAMINE 3/PGE-1 30 INJ INJECTABLELack of assurance of sterilityVita Pharmacy, LLC dba Talon Compounding Pharmacy · D-0217-2022Class IITerminatedNov 17, 2021TRI-MIX PAPAVERINE 30/PHENTOLAMINE 3/PGE-1 100 INJ INJECTABLELack of assurance of sterilityVita Pharmacy, LLC dba Talon Compounding Pharmacy · D-0216-2022Class IITerminatedNov 17, 2021TRI-MIX PAPAVERINE 30/PHENTOLAMINE 2/PGE-1 60 INJ INJECTABLELack of assurance of sterilityVita Pharmacy, LLC dba Talon Compounding Pharmacy · D-0215-2022